Angiogenix Report issue

For profit Phase 2
Founded: Burlingame CA United States (1997)
Status: Defunct (2005)

Organization Overview

First Clinical Trial
2006
NCT00351286
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now